MIDO Insulin Resistance

The strategy Integrated Measurement for Early Detection (MIDO), offers a new possibility to detect insulin resistance levels in pre-diabetes patients.  Dr. Hector Gallardo, Operational Solutions Director at the Carlos Slim Health Institute, explains this important development achieved in the CSHI, in alliance with scientists from North Carolina USA.

Carlos Slim Health Institute | Privacy Notice | Contact